CO2017011297A2 - Una composición farmacéutica antiviral de uso tópico - Google Patents

Una composición farmacéutica antiviral de uso tópico

Info

Publication number
CO2017011297A2
CO2017011297A2 CONC2017/0011297A CO2017011297A CO2017011297A2 CO 2017011297 A2 CO2017011297 A2 CO 2017011297A2 CO 2017011297 A CO2017011297 A CO 2017011297A CO 2017011297 A2 CO2017011297 A2 CO 2017011297A2
Authority
CO
Colombia
Prior art keywords
pharmaceutical composition
antiviral pharmaceutical
topical antiviral
topical
quaternary ammonium
Prior art date
Application number
CONC2017/0011297A
Other languages
English (en)
Inventor
Luis Alberto Argañarás
Original Assignee
Quim Luar S R L
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Quim Luar S R L filed Critical Quim Luar S R L
Publication of CO2017011297A2 publication Critical patent/CO2017011297A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Una composición farmacéutica antiviral de uso tópico contra aquellos virus con envoltura lipídica, que comprende como principios activos un copolímero catiónico conteniendo grupos aminos terciarios, y un tensioactivo catiónico conteniendo grupos amonios cuaternarios.
CONC2017/0011297A 2015-05-15 2017-11-02 Una composición farmacéutica antiviral de uso tópico CO2017011297A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ARP150101519A AR100459A1 (es) 2015-05-15 2015-05-15 Una composición farmacéutica antiviral de uso tópico
PCT/ES2016/070365 WO2016185069A1 (es) 2015-05-15 2016-05-13 Una composición farmacéutica antiviral de uso tópico

Publications (1)

Publication Number Publication Date
CO2017011297A2 true CO2017011297A2 (es) 2018-01-31

Family

ID=57319498

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2017/0011297A CO2017011297A2 (es) 2015-05-15 2017-11-02 Una composición farmacéutica antiviral de uso tópico

Country Status (11)

Country Link
US (1) US10478452B2 (es)
EP (1) EP3295934B1 (es)
AR (1) AR100459A1 (es)
BR (1) BR112017024399B1 (es)
CL (1) CL2017002796A1 (es)
CO (1) CO2017011297A2 (es)
ES (1) ES2915824T3 (es)
IL (1) IL255635A (es)
MX (1) MX2017014162A (es)
PE (1) PE20180396A1 (es)
WO (1) WO2016185069A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2022219944A1 (es) * 2021-04-16 2022-10-20

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3743727A (en) * 1970-11-16 1973-07-03 Crown Zellerbach Corp Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide
US4902720A (en) * 1983-01-10 1990-02-20 Baldone Joseph A Treatment of virus infections with quaternary ammonium compounds
US5160737A (en) * 1988-05-03 1992-11-03 Perio Products Ltd. Liquid polymer composition, and method of use
IL148801A0 (en) * 1999-09-24 2002-09-12 Janssen Pharmaceutica Nv Antiviral compositions
US6855341B2 (en) 2002-11-04 2005-02-15 Jeffrey B. Smith Anti-viral compositions and methods of making and using the anti-viral compositions
US7968122B2 (en) * 2003-12-10 2011-06-28 Adventrx Pharmaceuticals, Inc. Anti-viral pharmaceutical compositions
ITMI20051417A1 (it) * 2005-07-22 2007-01-23 Mipharm S P A Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina
US8119115B2 (en) * 2006-02-09 2012-02-21 Gojo Industries, Inc. Antiviral method
US7883487B2 (en) * 2008-06-16 2011-02-08 Shantha Totada R Transdermal local anesthetic patch with injection port
WO2012131669A1 (en) * 2011-03-29 2012-10-04 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Film-forming composition for a ph-dependant sustained release of the active agent

Also Published As

Publication number Publication date
EP3295934A1 (en) 2018-03-21
ES2915824T3 (es) 2022-06-27
EP3295934A4 (en) 2019-01-02
IL255635A (en) 2018-01-31
BR112017024399B1 (pt) 2022-06-07
US10478452B2 (en) 2019-11-19
EP3295934B1 (en) 2022-03-02
PE20180396A1 (es) 2018-02-28
WO2016185069A1 (es) 2016-11-24
BR112017024399A2 (pt) 2019-02-05
MX2017014162A (es) 2018-06-20
CL2017002796A1 (es) 2018-07-13
AR100459A1 (es) 2016-10-05
US20180250327A1 (en) 2018-09-06

Similar Documents

Publication Publication Date Title
BR112018011122A2 (pt) antígenos, vetores, composições, e métodos de utilização para o vírus da imunodeficiência humana dos mesmos
BR112015014482A2 (pt) vacinas para vírus influenza e seus usos
CL2016002269A1 (es) Moduladores alostéricos del núcleo proteico de la hepatitis b.
CO2017001994A2 (es) Compuestos activos hacia bromodominios
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
BR112018003110A2 (pt) nanopartículas terapêuticas compreendendo um agente terapêutico e métodos de fabricação e uso dos mesmos
CU20160187A7 (es) (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13, 13a-octahidro-2,5-metanopirido[1',2':4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio
BR112017028318A2 (pt) compostos antibacterianos
BR112015027321A8 (pt) Compostos e composições para modular a expressão de apolipoproteína(a) e seus usos
CL2015003615A1 (es) Nucleósidos sustituidos, nucleótidos y análogos de los mismos.
BR112016026291A2 (pt) Derivados do ácido borônico e usos terapêuticos dos mesmos
BR112015009189A2 (pt) conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo
MX2017009812A (es) Composiciones y metodos para inhibir infeccion viral.
BR112018002983A2 (pt) composição compreendendo uma lactama e um álcool
BR112017025781A2 (pt) derivados de 2-(pirazolopiridin-3-il)pirimidina como inibidores de jak
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
BR112016005417A8 (pt) "compostos derivados de desoxinojirimicina, composição farmacêutica e seus usos"
CO2017007316A2 (es) Formulación farmacéutica
MX2020011586A (es) Virus vaccinia quimerico sintetico.
BR112018004243A2 (pt) misturas biocidas
BR112017023425A2 (pt) combinações terapêuticas de terapias antivirais e anti-inflamatórias
CR20150145A (es) Composiciones con matriz de resina fundida en caliente
CO2017011297A2 (es) Una composición farmacéutica antiviral de uso tópico
WO2014113492A3 (en) Anti-viral compounds
EP4226937A3 (en) Non-neuroinvasive viruses and uses thereof